News | January 29, 2023
Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
